SPC
LTRN icon

Sigma Planning Corp’s Lantern Pharma LTRN Stock Holding History

Sigma Planning Corp’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-28,650
Closed -$101K – 1305
2025
Q1 		$101K Buy
28,650
+200
+0.7% +$830 ﹤0.01% 1162
2024
Q4 		$90.8K Sell
28,450
-200
-0.7% -$685 ﹤0.01% 1132
2024
Q3 		$105K Buy
28,650
+250
+0.9% +$1.03K ﹤0.01% 1166
2024
Q2 		$133K Buy
28,400
+1,550
+6% +$9.32K ﹤0.01% 1123
2024
Q1 		$236K Buy
26,850
+14,975
+126% +$80K 0.01% 1063
2023
Q4 		$50.8K Sell
11,875
-6,250
-34% -$22K ﹤0.01% 828
2023
Q3 		$61.8K Hold
18,125
– – ﹤0.01% 1155
2023
Q2 		$102K Buy
18,125
+850
+5% +$4.39K ﹤0.01% 1148
2023
Q1 		$83.4K Sell
17,275
-25
-0.1% -$131 ﹤0.01% 1250
2022
Q4 		$104K Sell
17,300
-200
-1% -$1K ﹤0.01% 1196
2022
Q3 		$84K Sell
17,500
-100
-0.6% -$538 ﹤0.01% 1200
2022
Q2 		$100K Hold
17,600
– – ﹤0.01% 1219
2022
Q1 		$126K Hold
17,600
– – ﹤0.01% 1292
2021
Q4 		$140K Buy
+17,600
New +$161K ﹤0.01% 1306

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Sigma Planning Corp's LTRN Position: Q2 2025 in Review

Sigma Planning Corp sold out of Lantern Pharma (LTRN) in Q2 2025, closing a stake of 28,650 shares — an estimated $101K sold.

Sigma Planning Corp first reported a position in LTRN in Q4 2021 and held it in 14 quarters. The position peaked at $236K in Q1 2024. 35 funds tracked by Wall St. Rank hold LTRN as of Q2 2025.

  • Sigma Planning Corp reported no remaining Lantern Pharma position as of Q2 2025 after selling out during the quarter.
  • Sigma Planning Corp sold 28,650 Lantern Pharma shares in Q2 2025, an estimated $101K.
  • Sigma Planning Corp first reported a position in Lantern Pharma in Q4 2021 and held it in 14 quarters.
  • Sigma Planning Corp's Lantern Pharma position peaked at $236K in Q1 2024.
  • 35 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2025.

Based on Sigma Planning Corp's 13F filing for Q2 2025, filed 5 Aug 2025.